Balance Sheet

v3.26.1

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 70,091	$ 216,890
Accounts receivable, net	31,138	25,498
Inventory	41,230	40,495
Prepaid expenses and other current assets	13,196	13,368
Total current assets	155,655	296,251
Property and equipment, net	142,414	151,479
Goodwill	129,429	129,429
Intangible assets, net	138,375	151,543
Other assets	37,873	41,875
Total assets	603,746	770,577
Current liabilities:
Accounts payable	7,125	2,910
Accrued expenses and other current liabilities	30,169	36,567
Current portion of long-term debt	1,125	5,440
Total current liabilities	38,419	44,917
Long-term debt, less current portion	145,980	286,331
Finance lease liabilities, less current portion	29,591	30,141
Other long-term liabilities	34,168	36,477
Total liabilities	248,158	397,866
Commitments and contingencies (Note 5)
Stockholders’ equity:
Additional paid-in capital	207,598	199,177
Retained earnings (accumulated deficit)	(6,031)	10,118
Accumulated other comprehensive income	459	524
Total stockholders’ equity attributable to Maravai LifeSciences Holdings, Inc.	204,622	212,379
Non-controlling interest	150,966	160,332
Total stockholders’ equity	355,588	372,711
Total liabilities and stockholders’ equity	603,746	770,577
Class A Common Stock
Stockholders’ equity:
Common stock	1,489	1,453
Class B Common Stock
Stockholders’ equity:
Common stock	$ 1,107	$ 1,107

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Source